Reduced synchroneity of intra-islet Ca2+ oscillations in vivo in Robo-deficient β cells

  1. Melissa T Adams
  2. JaeAnn M Dwulet
  3. Jennifer K Briggs
  4. Christopher A Reissaus
  5. Erli Jin
  6. Joseph M Szulczewski
  7. Melissa R Lyman
  8. Sophia M Sdao
  9. Vira Kravets
  10. Sutichot D Nimkulrat
  11. Suzanne M Ponik
  12. Matthew J Merrins
  13. Raghavendra G Mirmira
  14. Amelia K Linnemann
  15. Richard KP Benninger
  16. Barak Blum  Is a corresponding author
  1. University of Wisconsin-Madison, United States
  2. University of Colorado Denver, Anschutz Medical Campus, United States
  3. Indiana University School of Medicine, United States
  4. University of Colorado-Denver, United States
  5. University of Chicago, United States

Abstract

The spatial architecture of the islets of Langerhans is hypothesized to facilitate synchronized insulin secretion among β cells yet testing this in vivo in the intact pancreas is challenging. Robo βKO mice, in which the genes Robo1 and Robo2 are deleted selectively in β cells, provide a unique model of altered islet spatial architecture without loss of β cell differentiation or islet damage from diabetes. Combining Robo βKO mice with intravital microscopy, we show here that Robo βKO islets have reduced synchronized intra-islet Ca2+ oscillations among β cells in vivo. We provide evidence that this loss is not due to a β cell-intrinsic function of Robo, mis-expression or mis-localization of Cx36 gap junctions, or changes in islet vascularization or innervation, suggesting that the islet architecture itself is required for synchronized Ca2+ oscillations. These results have implications for understanding structure-function relationships in the islets during progression to diabetes as well as engineering islets from stem cells.

Data availability

All data generated or analyzed during this study are included in the manuscript and supporting files.

Article and author information

Author details

  1. Melissa T Adams

    Department of Cell and Regenerative Biology, University of Wisconsin-Madison, Madison, United States
    Competing interests
    The authors declare that no competing interests exist.
  2. JaeAnn M Dwulet

    Department of Bioengineering and Barbara Davis Center for Diabetes, University of Colorado Denver, Anschutz Medical Campus, Aurora, United States
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-2519-5193
  3. Jennifer K Briggs

    Department of Bioengineering and Barbara Davis Center for Diabetes, University of Colorado Denver, Anschutz Medical Campus, Aurora, United States
    Competing interests
    The authors declare that no competing interests exist.
  4. Christopher A Reissaus

    Herman B Wells Center for Pediatric Research and Center for Diabetes and Metabolic Diseases, Indiana University School of Medicine, Indianapolis, United States
    Competing interests
    The authors declare that no competing interests exist.
  5. Erli Jin

    Department of Medicine, Division of Endocrinology, Diabetes, and Metabolism, University of Wisconsin-Madison, Madison, United States
    Competing interests
    The authors declare that no competing interests exist.
  6. Joseph M Szulczewski

    Department of Cell and Regenerative Biology, University of Wisconsin-Madison, Madison, United States
    Competing interests
    The authors declare that no competing interests exist.
  7. Melissa R Lyman

    Department of Cell and Regenerative Biology, University of Wisconsin-Madison, Madison, United States
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-0091-0413
  8. Sophia M Sdao

    Department of Medicine, Division of Endocrinology, Diabetes, and Metabolism, University of Wisconsin-Madison, Madison, United States
    Competing interests
    The authors declare that no competing interests exist.
  9. Vira Kravets

    Bioengineering, University of Colorado-Denver, Aurora, United States
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-5147-309X
  10. Sutichot D Nimkulrat

    Department of Cell and Regenerative Biology, University of Wisconsin-Madison, Madison, United States
    Competing interests
    The authors declare that no competing interests exist.
  11. Suzanne M Ponik

    Cell and Regenerative Biology, University of Wisconsin-Madison, Madison, United States
    Competing interests
    The authors declare that no competing interests exist.
  12. Matthew J Merrins

    Department of Medicine, Division of Endocrinology, Diabetes, and Metabolism, University of Wisconsin-Madison, Madison, United States
    Competing interests
    The authors declare that no competing interests exist.
  13. Raghavendra G Mirmira

    Kovler Diabetes Center and the Department of Medicine, University of Chicago, Chicago, United States
    Competing interests
    The authors declare that no competing interests exist.
  14. Amelia K Linnemann

    Herman B Wells Center for Pediatric Research and Center for Diabetes and Metabolic Diseases, Indiana University School of Medicine, Indianapolis, United States
    Competing interests
    The authors declare that no competing interests exist.
  15. Richard KP Benninger

    Department of Bioengineering and Barbara Davis Center for Diabetes, University of Colorado Denver, Anschutz Medical Campus, Aurora, United States
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-5063-6096
  16. Barak Blum

    Department of Cell and Regenerative Biology, University of Wisconsin-Madison, Madison, United States
    For correspondence
    bblum4@wisc.edu
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-5308-4194

Funding

National Institute of Diabetes and Digestive and Kidney Diseases (R01DK121706)

  • Barak Blum

American Diabetes Association (ADA 1-16-IBS-212)

  • Matthew J Merrins

National Institute of General Medical Sciences (5T32GM007133-44)

  • Melissa T Adams

National Institute of Diabetes and Digestive and Kidney Diseases (P30DK020579)

  • Barak Blum

UW-Madison Institute for Clinical and Translational Research (UL1TR000427)

  • Matthew J Merrins
  • Barak Blum

National Institute of Diabetes and Digestive and Kidney Diseases (R01DK060581)

  • Raghavendra G Mirmira

National Institute of Diabetes and Digestive and Kidney Diseases (R01DK102950)

  • Richard KP Benninger

National Institute of Diabetes and Digestive and Kidney Diseases (R01DK106412)

  • Richard KP Benninger

National Cancer Institute (R01CA216248)

  • Suzanne M Ponik

National Institute of Diabetes and Digestive and Kidney Diseases (R01DK113103)

  • Matthew J Merrins

National Institute on Aging (R01AG062328)

  • Matthew J Merrins

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Animal experimentation: The experimental protocol for animal usage was reviewed and approved by the University of Wisconsin-Madison Institutional Animal Care and Use Committee (IACUC) under Protocol #M005221 and Protocol #M005333, and all animal experiments were conducted in accordance with the University of Wisconsin-Madison IACUC guidelines under the approved protocol.

Copyright

© 2021, Adams et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 2,164
    views
  • 229
    downloads
  • 19
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Melissa T Adams
  2. JaeAnn M Dwulet
  3. Jennifer K Briggs
  4. Christopher A Reissaus
  5. Erli Jin
  6. Joseph M Szulczewski
  7. Melissa R Lyman
  8. Sophia M Sdao
  9. Vira Kravets
  10. Sutichot D Nimkulrat
  11. Suzanne M Ponik
  12. Matthew J Merrins
  13. Raghavendra G Mirmira
  14. Amelia K Linnemann
  15. Richard KP Benninger
  16. Barak Blum
(2021)
Reduced synchroneity of intra-islet Ca2+ oscillations in vivo in Robo-deficient β cells
eLife 10:e61308.
https://doi.org/10.7554/eLife.61308

Share this article

https://doi.org/10.7554/eLife.61308

Further reading

    1. Biochemistry and Chemical Biology
    2. Cell Biology
    Birol Cabukusta, Shalom Borst Pauwels ... Jacques Neefjes
    Research Article

    Numerous lipids are heterogeneously distributed among organelles. Most lipid trafficking between organelles is achieved by a group of lipid transfer proteins (LTPs) that carry lipids using their hydrophobic cavities. The human genome encodes many intracellular LTPs responsible for lipid trafficking and the function of many LTPs in defining cellular lipid levels and distributions is unclear. Here, we created a gene knockout library targeting 90 intracellular LTPs and performed whole-cell lipidomics analysis. This analysis confirmed known lipid disturbances and identified new ones caused by the loss of LTPs. Among these, we found major sphingolipid imbalances in ORP9 and ORP11 knockout cells, two proteins of previously unknown function in sphingolipid metabolism. ORP9 and ORP11 form a heterodimer to localize at the ER-trans-Golgi membrane contact sites, where the dimer exchanges phosphatidylserine (PS) for phosphatidylinositol-4-phosphate (PI(4)P) between the two organelles. Consequently, loss of either protein causes phospholipid imbalances in the Golgi apparatus that result in lowered sphingomyelin synthesis at this organelle. Overall, our LTP knockout library toolbox identifies various proteins in control of cellular lipid levels, including the ORP9-ORP11 heterodimer, which exchanges PS and PI(4)P at the ER-Golgi membrane contact site as a critical step in sphingomyelin synthesis in the Golgi apparatus.

    1. Cell Biology
    2. Neuroscience
    Georg Kislinger, Gunar Fabig ... Martina Schifferer
    Tools and Resources

    Like other volume electron microscopy approaches, automated tape-collecting ultramicrotomy (ATUM) enables imaging of serial sections deposited on thick plastic tapes by scanning electron microscopy (SEM). ATUM is unique in enabling hierarchical imaging and thus efficient screening for target structures, as needed for correlative light and electron microscopy. However, SEM of sections on tape can only access the section surface, thereby limiting the axial resolution to the typical size of cellular vesicles with an order of magnitude lower than the acquired xy resolution. In contrast, serial-section electron tomography (ET), a transmission electron microscopy-based approach, yields isotropic voxels at full EM resolution, but requires deposition of sections on electron-stable thin and fragile films, thus making screening of large section libraries difficult and prone to section loss. To combine the strength of both approaches, we developed ‘ATUM-Tomo, a hybrid method, where sections are first reversibly attached to plastic tape via a dissolvable coating, and after screening detached and transferred to the ET-compatible thin films. As a proof-of-principle, we applied correlative ATUM-Tomo to study ultrastructural features of blood-brain barrier (BBB) leakiness around microthrombi in a mouse model of traumatic brain injury. Microthrombi and associated sites of BBB leakiness were identified by confocal imaging of injected fluorescent and electron-dense nanoparticles, then relocalized by ATUM-SEM, and finally interrogated by correlative ATUM-Tomo. Overall, our new ATUM-Tomo approach will substantially advance ultrastructural analysis of biological phenomena that require cell- and tissue-level contextualization of the finest subcellular textures.